Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 26,372,338 | 28,857,675 | 66,463,265 | 81,248,781 | 101,839,575 | 304,781,634 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | 0 | |||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | |||||
| 4 | Total. Add lines 1 through 3 | 26,372,338 | 28,857,675 | 66,463,265 | 81,248,781 | 101,839,575 | 304,781,634 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 74,918,172 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 229,863,462 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 26,372,338 | 28,857,675 | 66,463,265 | 81,248,781 | 101,839,575 | 304,781,634 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 8,099,714 | 9,475,198 | 16,986,988 | 11,840,636 | 8,463,864 | 54,866,400 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 85,082 | 797,090 | 1,055,622 | 902,711 | 956,650 | 3,797,155 |
| 11 | Total support. Add lines 7 through 10 | 363,445,189 | |||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 39,674,936 | 15,420,347 | 6,256,925 | 8,500 | 61,360,708 | |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 294,499,080 | 282,187,377 | 273,373,751 | 293,993,460 | 182,180,608 | 1,326,234,276 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | |||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | |||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | |||||
| 6 | Total. Add lines 1 through 5 | 294,499,080 | 321,862,313 | 288,794,098 | 300,250,385 | 182,189,108 | 1,387,594,984 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | 0 | 0 | 0 | 0 | 0 |
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | 0 | 0 | 0 | 0 | 0 |
| c | Add lines 7a and 7b.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 8 | Public support. (Subtract line 7c from line 6.) | 1,387,594,984 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 294,499,080 | 321,862,313 | 288,794,098 | 300,250,385 | 182,189,108 | 1,387,594,984 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 21,170,947 | 8,704,357 | 4,018,129 | 5,973,886 | -4,858,365 | 35,008,954 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 521,525 | 8,208 | 529,733 | |||
| c | Add lines 10a and 10b. | 21,692,472 | 8,712,565 | 4,018,129 | 5,973,886 | -4,858,365 | 35,538,687 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 0 | |||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 99,730,481 | 10,094,471 | 11,332,019 | 11,495,112 | 84,637,484 | 217,289,567 |
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 415,922,033 | 340,669,349 | 304,144,246 | 317,719,383 | 261,968,227 | 1,640,423,238 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2023 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2023 |
(iii) Distributable Amount for 2023 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2023 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2023 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2023: | ||||
| a From 2018....... | ||||
| b From 2019....... | ||||
| c From 2020....... | ||||
| d From 2021....... | ||||
| e From 2022....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2023 distributable amount | ||||
|
i
Carryover from 2018 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2023 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2023 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2023, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2023. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2024. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2019..... | ||||
| b Excess from 2020..... | ||||
| c Excess from 2021..... | ||||
| d Excess from 2022..... | ||||
| e Excess from 2023..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| Schedule A, Part I PUBLIC CHARITY STATUS OF SUBORDINATES | THE PUBLIC CHARITY STATUS REFLECTED ON SCHEDULE A, PART I IS FOR THE ELEVEN FOUNDATIONS INCLUDED IN THIS GROUP FORM 990 AS THEY REPRESENT THE LARGEST NUMBER OF SUBORDINATES IN A SPECIFIC PUBLIC CHARITY STATUS. THESE ORGANIZATIONS DESCRIBED IN INTERNAL REVENUE CODE SECTION 170(B)(1)(A)(VI) AND INCLUDED IN THE GROUP EXEMPTION RULING ARE HACKENSACK MERIDIAN HEALTH FOUNDATION, INC., HACKENSACK UNIVERSITY MEDICAL CENTER FOUNDATION,INC., JERSEY SHORE UNIVERSITY MEDICAL CENTER FOUNDATION, INC., RIVERVIEW MEDICAL CENTER FOUNDATION, INC., OCEAN UNIVERSITY MEDICAL CENTER FOUNDATION,INC., SOUTHERN OCEAN MEDICAL CENTER FOUNDATION, INC., BAYSHORE MEDICAL CENTER FOUNDATION, INC., RARITAN BAY HEALTHCARE FOUNDATION,INC., PALISADES MEDICAL CENTER FOUNDATION, INC., JFK UNIVERSITY MEDICAL CENTER FOUNDATION,INC., AND MUHLENBERG FOUNDATION, INC. OUTLINED BELOW IS THE PUBLIC CHARITY STATUS FOR ALL OTHER SUBORDINATE ORGANIZATIONS INCLUDED IN THE GROUP EXEMPTION RULING AND THIS CONSOLIDATED GROUP FORM 990: HMH HOSPITALS CORPORATION; SCHEDULE A, PART I, LINE 3, INTERNAL REVENUE CODE SECTION 170(B)(1)(A)(III) ORGANIZATION; HEALTH INNOVATIONS UNLIMITED, INC.; SCHEDULE A, PART I, LINE 10, INTERNAL REVENUE CODE SECTION 509(A)(2) ORGANIZATION; HACKENSACK MERIDIAN AMBULATORY CARE, INC.; SCHEDULE A, PART I, LINE 10, INTERNAL REVENUE CODE SECTION 509(A)(2) ORGANIZATION; BERGEN HEALTH MANAGEMENT SYSTEM, INC.; SCHEDULE A, PART I, LINE 2, INTERNAL REVENUE CODE SECTION 509(A)(1) ORGANIZATION; MUHLENBERG REGIONAL MEDICAL CENTER, INC.; SCHEDULE A, PART I, LINE 10, INTERNAL REVENUE CODE SECTION 509(A)(2) ORGANIZATION; HARTWYCK AT OAK TREE, INC.; SCHEDULE A, PART I, LINE 10, INTERNAL REVENUE CODE SECTION 509(A)(2) ORGANIZATION; HACKENSACK MERIDIAN OUTPATIENT SERVICES, INC.; SCHEDULE A, PART I, LINE 10, INTERNAL REVENUE CODE SECTION 509(A)(2) ORGANIZATION; HMH CARRIER CLINIC, INC.; SCHEDULE A, PART I, LINE 3, INTERNAL REVENUE CODE SECTION 170(B)(1)(A)(III) ORGANIZATION. CENTER FOR DISCOVERY AND INNOVATION, INC.; SCHEDULE A, PART I, LINE 4, INTERNAL REVENUE CODE SECTION 170(B)(1)(A)(III) ORGANIZATION. HACKENSACK MERIDIAN SCHOOL OF MEDICINE; SCHEDULE A, PART I, LINE 2, INTERNAL REVENUE CODE SECTION 170(B)(1)(A)(II) ORGANIZATION. |
| Schedule A, Part II, Line 1 UNUSUAL GRANTS | UNUSUAL GRANTS EXCLUDED FROM SCHEDULE A, PART II, SECTION A, LINE 1 INCLUDE: 2019: $5,000,000 AND $3,006,000 2020: $7,182,040 AND $8,000,000 2021: $5,000,000 2022: NONE 2023: NONE |
| Schedule A, Part III, Line 12 Other Income | DESCRIPTION - MISCELLANEOUS INCOME, MANAGEMENT FEES, AND SALE OF INVENTORY NET INCOME, COLUMN A - 99730481.0, COLUMN B - 10094471.0, COLUMN C - 11332019.0, COLUMN D - 11495112.0, COLUMN E - 84637484.0, COLUMN F - XXX-XX-XXXX.0; |
| Schedule A, Part II, Line 10 Other Income | DESCRIPTION - GAMING NET INCOME AND SALE OF INVENTORY NET INCOME, COLUMN A - 85082.0, COLUMN B - 797090.0, COLUMN C - 1055622.0, COLUMN D - 902711.0, COLUMN E - 956650.0, COLUMN F - 3797155.0; |
| Software ID: | 23017437 |
| Software Version: | 2023v5.1 |
| Return Reference | Explanation |
|---|---|
| Schedule E, Part I, Line 3 RACIALLY NONDISCRIMINATORY POLICY | BERGEN HEALTH MANAGEMENT SYSTEM, INC. LISTED ITS NON-DISCRIMINATORY POLICY IN ITS BROCHURE/PAMPHLETS WHICH IS PROVIDED TO ALL PROSPECTIVE AND ENROLLED PATIENTS AND IS ALSO AVAILABLE UPON REQUEST. HACKENSACK MERIDIAN SCHOOL OF MEDICINE ("HMSOM") RECEIVED PRELIMINARY ACCREDITATION IN 2018 AND PROVISIONAL STATUS IN FEBRUARY 2021 FROM THE MIDDLE STATES COMMISSION ON HIGHER EDUCATION (MSCHE), A BODY OF THE ASSOCIATION OF AMERICAN MEDICAL COLLEGES. HMSOM SUBMITTED ALL REQUIRED DOCUMENTATION FOR AND HOSTED A SITE EVALUATION TEAM THAT REVIEWED THE SCHOOL'S APPLICATION TOWARD FULL ACCREDITATION STATUS. AFTER A ROBUST SEVEN-YEAR REVIEW PROCESS, HMSOM HAS BEEN GRANTED FULL ACCREDITATION BY MSCHE IN FEBRUARY 2023. |
| Schedule E, Part I, Line 6(a) FINANCIAL AID OR ASSISTANCE FROM A GOVERNMENT | BERGEN HEALTH MANAGEMENT SYSTEM, INC. RECEIVED A TUITION SUBSIDY FROM THE NJ AMERICAN RESCUE PLAN (ARP) STABILIZATION GRANT. HACKENSACK MERIDIAN SCHOOL OF MEDICINE RECEIVED FINANCIAL AID AND ASSISTANCE FROM THE FOLLOWING GOVERNMENT AGENCIES IN TAX YEAR 2023 INCLUDING: THE NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY (NJEDA), THE NEW JERSEY STATE LEGISLATURE, AND THE STATE OF NEW JERSEY THROUGH THE AMERICAN RESCUE PLAN ACT (ARPA). |
| Software ID: | 23017437 |
| Software Version: | 2023v5.1 |
| Return Reference | Explanation |
|---|---|
| Form 990, Part I, Line 1 summary | OUTLINED BELOW IS THE VOTING AND INDEPENDENT VOTING DISCLOSURE INFORMATION FOR EACH SUBORDINATE ORGANIZATION INCLUDED IN THE GROUP EXEMPTION RULING AND THIS CONSOLIDATED GROUP FORM 990 (SOME BOARD MEMBERS SERVE ON MULTIPLE BOARDS AS INDICATED IN THE PART VII DISCLOSURE INCLUDED IN SCHEDULE O): - HMH HOSPITALS CORPORATION; 23 VOTING, 15 INDEPENDENT; - HACKENSACK MERIDIAN AMBULATORY CARE INC.; 17 VOTING, 14 INDEPENDENT; - HEALTH INNOVATIONS UNLIMITED, INC.; 17 VOTING, 14 INDEPENDENT; -HACKENSACK MERIDIAN HEALTH FOUNDATION, INC.; 33 VOTING, 26 INDEPENDENT; - HACKENSACK UNIVERSITY MEDICAL CENTER FOUNDATION, INC.; 42 VOTING, 36 INDEPENDENT; - JERSEY SHORE UNIVERSITY MEDICAL CENTER FOUNDATION, INC.; 23 VOTING, 14 INDEPENDENT; - RIVERVIEW MEDICAL CENTER FOUNDATION, INC.; 23 VOTING, 19 INDEPENDENT; - OCEAN UNIVERSITY MEDICAL CENTER FOUNDATION, INC.; 18 VOTING, 15 INDEPENDENT; - SOUTHERN OCEAN MEDICAL CENTER FOUNDATION, INC.; 22 VOTING; 17 INDEPENDENT; - BAYSHORE MEDICAL CENTER FOUNDATION, INC.; 18 VOTING; 13 INDEPENDENT; - RARITAN BAY HEALTHCARE FOUNDATION, INC.; 8 VOTING, 5 INDEPENDENT; - PALISADES MEDICAL CENTER FOUNDATION, INC.; 12 VOTING, 10 INDEPENDENT; - JOHN F. KENNEDY UNIVERSITY MEDICAL CENTER FOUNDATION, INC.; 24 VOTING, 22 INDEPENDENT; - MUHLENBERG FOUNDATION, INC.; 5 VOTING, 5 INDEPENDENT; - BERGEN HEALTH MANAGEMENT SYSTEM, INC.; 3 VOTING, 0 INDEPENDENT; - MUHLENBERG REGIONAL MEDICAL CENTER, INC.; 4 VOTING, 2 INDEPENDENT; - HARTWYCK AT OAK TREE, INC.; 17 VOTING, 14 INDEPENDENT; - HACKENSACK MERIDIAN OUTPATIENT SERVICES, INC.; 17 VOTING, 14 INDEPENDENT; -HACKENSACK MERIDIAN SCHOOL OF MEDICINE; 15 VOTING, 14 INDEPENDENT; - CENTER FOR DISCOVERY AND INNOVATION; 11 VOTING, 10 INDEPENDENT; AND - HACKENSACK MERIDIAN HEALTH CARRIER CLINIC, INC.; 12 VOTING, 10 INDEPENDENT. |
| Form 990, Part III, Line 1 STATEMENT OF PROGRAM SERVICES ACCOMPLISHMENTS | HACKENSACK MERIDIAN HEALTH ============================ WE ARE THE LARGEST, MOST COMPREHENSIVE AND TRULY INTEGRATED HEALTH CARE NETWORK IN NEW JERSEY, OFFERING A COMPLETE RANGE OF MEDICAL SERVICES, INNOVATIVE RESEARCH AND LIFE-ENHANCING CARE. WHO WE ARE ============ -18 HOSPITALS -- 3 ACADEMIC MEDICAL CENTERS -- 1 UNIVERSITY TEACHING HOSPITAL -- 8 COMMUNITY HOSPITALS -- 2 REHABILITATION HOSPITALS -- 2 CHILDREN'S HOSPITALS -- 1 BEHAVIORAL HEALTH HOSPITAL -- 1 LONG TERM ACUTE CARE HOSPITAL - 1 CENTER FOR DISCOVERY & INNOVATION - 1 SCHOOL OF MEDICINE - 4,712 LICENSED BEDS - 500+ PATIENT CARE LOCATIONS - 7,000+ PHYSICIANS - 37,000+ TEAM MEMBERS CARE DELIVERED IN 2023 ======================== - 180,857 PATIENT ADMISSIONS - 676,491 EMERGENCY VISITS - 2,058,577 OUTPATIENT VISITS - 16,381 BABIES DELIVERED - 115,181 SURGERIES (INPATIENT AND OUTPATIENT) FACILITIES =========== CONTINUALLY UPGRADING OUR FACILITIES IS CRUCIAL FOR ENHANCING PATIENT CARE AND SAFETY AND FOSTERING A POSITIVE WORK ENVIRONMENT SO WE CAN CONTINUE TO DELIVER THE HIGHEST QUALITY OF CARE TO THE COMMUNITY. WE ARE COMMITTED TO DELIVERING THE BEST ENVIRONMENT FOR OUR PATIENTS, PHYSICIANS AND TEAM MEMBERS. Jersey Shore University Medical Center =========== In 2023, Jersey Shore University Medical Center broke ground on a brand new, state-of-the-art cardiovascular suite. The $45 million, 30,000-square-foot expansion project will provide patients with a one-stop-shop for comprehensive cardiovascular treatment and is expected to open in the fourth quarter of 2024. Features include: -10 new labs outfitted with the most advanced technology, including: -4 dedicated cardiac catheterization labs, uniquely equipped with intravascular Optical Coherence Tomography (OCT) technology to precisely identify plaque deposits from inside the artery -4 electrophysiology labs to perform minimally invasive left atrial appendage occlusion procedures (Watchman and Amulet devices) and offer innovative ablation treatment -2 hybrid operating rooms featuring Siemens Healthineers ARTIS icono biplane imaging technology for complex minimally invasive procedures (i.e. TAVR, MitraClip and cardiac catheterization/PCI) or convert to an open procedure if necessary -Expanded 28-bay patient prep and recovery area tripling current patient capacity -Centralized location, closer to the ED and ORs -Design and functionality created with input from physicians, nurses, technicians and other hands-on experts High-Quality Perinatal Care Jersey Shore University Medical Center and JFK University Medical Center have been redesignated as Baby-Friendly Hospitals. The Baby-Friendly Hospital Initiative is an international health program that promotes evidence-based infant feeding practices to ensure all families receive the support needed to meet their feeding goals, ultimately improving the health of women and children in the community. We are extremely proud to be recognized for the hard work of our team members throughout the Baby-Friendly process in receiving this exclusive designation. Newly Unveiled Neuroscience Treatment Center In January 2023, Jersey Shore University Medical Center celebrated the opening of the Harris Neuroscience Treatment Center. The expansive, nearly 10,000 sq. foot, combined physician office and treatment center is home to experts in several neurological diseases and conditions and is part of Hackensack Meridian Neuroscience Institute. Patients can visit their physicians and other providers at the center to receive advanced diagnostic testing and treatments in a range of conditions, including; ALS (amyotrophic lateral sclerosis) and other neuromuscular disorders; Parkinson's disease, essential tremor, dystonia and other movement disorders; neuro-oncology including brain and spine tumor treatments; epilepsy and seizure disorders; headaches and migraines and stroke prevention. HMH Carrier Behavioral Health ========== Carrier Clinic Expertise Meets Raritan Bay Community In early 2023 we announced the expansion of the Carrier Clinic brand to Raritan Bay Medical Center, and introduced Carrier Behavioral Health. The move strengthens the delivery of award-winning behavioral health care services to individuals in the Raritan Bay service area. For over a century, Carrier Clinic has been a world-class facility for behavioral health needs in the tri-state region and ranks among the top psychiatric and substance use disorders rehab recovery centers in New Jersey, offering comprehensive behavioral and addiction treatment services. The new Carrier Behavioral Health expansion increases capacity from 24 beds to 81 as part of Hackensack Meridian Health's $35 million investment into Raritan Bay Medical Center, and fully opened to the public in the fall 2023. The partnership combines Carrier Clinic's expertise with Raritan Bay Medical Center's expanded behavioral health services, programs, and facilities to meet the needs of patients. First-of-Its-Kind Surgery Center & Stay Suites Opens in New Jersey Hackensack Meridian Health launched a first-of-its- kind hyper specialized musculoskeletal ambulatory surgery center (ASC) in New Jersey. In partnership with ValueHealth LLC, a nationally recognized leader in Ambulatory Centers of Excellence (ACE)TM, and Surgery Partners, one of the country's leading ASC management companies, the new state-of-the-art Hackensack Musculoskeletal Surgery Center, opened on the campus of Hackensack University Medical Center. Hackensack Musculoskeletal Stay Suites, an affiliated and partnered entity co-located in the same building as the surgery center, will offer patients an extended-stay opportunity in an innovative, recovery-focused environment following joint replacement procedures. The combined ASC and Stay Suites facility will offer ValueHealth's Muve program for hip and knee replacement patients, which is a comprehensive episode-of-care program that services patients preoperatively and postoperatively for a full year. The Muve program has demonstrated superior outcomes for joint replacement patients throughout ValueHealth's network of partnerships across the country. JFK University Medical Center ========= New MRI Enhances Image Quality and Patient Comfort JFK University Medical Center is the second facility in New Jersey to offer the MAGNETOM Vida 3T MRI, which adapts to unique patient needs such as weight and anatomy and provides a more precise and faster MRI experience than traditional MRI technologies. The system uses very powerful magnets that produce a specialized 3-Tesla magnetic field, which is about twice as powerful as the fields used in conventional high-field MRI scanners, and as much as 15 times stronger than low-field or open MRI scanners. This enables the MRI to provide physicians with high-quality, high-resolution images of the inside of the body. The new MRI's BioMatrix Technology - a groundbreaking collection of sensors, tuners, and interfaces - enables the scanner to adapt automatically to anatomical and physiological characteristics to provide consistent, high-quality imaging for all patient types. This decreases the need for rescans and increases scan consistency across a diverse patient population. Ocean University Medical Center ========== A New Level of Heart and Vascular Care In early 2023, we announced the opening of the Harris Heart & Vascular Center at Ocean University Medical Center. The major investment spans 17,750 square feet, doubling the size of the hospital's previous catheterization lab. The Harris Heart & Vascular Center provides a one-stop-shop for heart and vascular care, accommodating the growing number of procedures performed at the medical center and surrounding hospitals. The center is equipped with: -3 multi-purpose catheterization/vascular labs and a hybrid OR, which enable more efficient preparation, treatment, and recovery for patients. -Cutting-edge technologies that help physicians provide safer, minimally invasive treatments. -Live patient tracking systems to ensure that caregivers are kept informed every step of the way throughout the patient's stay. By providing both diagnostic and minimally- invasive surgical functions in one space, clinicians can diagnose heart and vascular conditions and offer immediate surgical treatment without delay, ensuring higher efficiency and safety for certain high-risk procedures. |
| Form 990, Part III, Line 1 STMT OF PROGRAM SERVICES ACCOMPLISHMENTS (CONTINUED) | Access to Care ============ Hackensack Meridian is dedicated to improving access to care for patients and the community, ensuring timely and equitable health care services for all. Medical Group Continues to Grow Our Hackensack Meridian Medical Group, which includes more than 2,185 physicians and advanced providers at over 380 locations, experienced significant growth in 2023 with the addition of more than 350 new practitioners, 20 practice locations, and 12 new practices. We are dedicated to improving access to care for our patients and the community, and have welcomed primary care physicians as well as a diverse group of specialists to the team last year, including rheumatologists, colorectal, thoracic, trauma and general surgeons, neurologists, pediatric subspecialists and urologists. Hackensack Meridian Medical Group 2023 Stats - +350 New Practitioners - +12 New Practices - 1.8 million Patient Visits (up 10% over 2022) - Reached 7,500 Daily Appointments - 5.6% of Appointments done Via Telehealth - 33% Increase in Online Appointment Scheduling (51% of online appointments scheduled by new patients and 31% were scheduled during non-work hours) One-Stop-Shop for Wellness As part of a multi-year ambulatory strategy focused on improving access to care close to home, Hackensack Meridian Health opened a new Health & Wellness Center in Clark, New Jersey, providing easy, one-stop access to various health care services in Union County. The opening of the Clark location follows the Eatontown Health & Wellness Center opening in 2022. The new center brings together adult primary care clinicians along with other adult specialties, including: . Cardiology . Neurology . Women's Services . Gynecologic Oncology . Obstetrics & Gynecology . Urgent Care The Health & Wellness Center's Urgent Care Center offers convenient hours, including nights and weekends, and provides walk-in care for everyday illness and injury. Advanced services - including virtual visits, imaging, labs, minor surgery, stitches and treatment for broken bones, sprains or strains - are also available. Meeting Patients Where They Are The new Health & Wellness Center in Clark and Urgent Care Center in Lincoln Park that opened in 2023 are only part of a massive investment underway to improve access to care for the community. Twenty-six outpatient care sites that provide a range of convenient services recently opened, or are under construction, representing half a million square feet. In 2023, we experienced: - 26 New Ambulatory Care Sites - 2M+ Outpatient Visits - 215K Imaging Patients - 158K Patients Receiving Dialysis - 114K Urgent Care Visits - 69K Patients Utilizing Our Ambulatory Surgery Centers Expanding Remote Access to Critical Behavioral Health Services Hackensack Meridian Health expanded its use of telehealth and virtual visits for behavioral health services to improve access to care in 2023. Behavioral health telehealth services are now offered at the following locations: --Pediatrician offices in partnership with the NJ Pediatric Psychiatry Collaborative --EPS (emergency psychiatric stabilization) units at all hospital emergency departments --Walk-in Urgent Care in Neptune --Many Hackensack Meridian Medical Group physician offices The network also developed and launched its "Bridge Care" services - an innovative model that provides transitional care, resources and support to patients who may have been seen at urgent care or hospital emergency rooms. Patients can now receive follow-up care through virtual or in person visits as their care team coordinates an expedited appointment with a behavioral health care provider. Use of telehealth reached further into our physician network to provide overnight virtual visit coverage at our hospitals, reducing the need for behavioral health physicians to be on-site and on call, which contributed to their mental health and wellness, retention and recruitment. Investing in Digital to Connect Patients to Care Embracing technology to improve access to care is vital to making access to care easier for our patients. Hackensack Meridian Health has made significant investments to ensure patients have a streamlined and seamless experience when they enter our system. This starts with a digital front door, focused on connecting patients to care through web, text and mobile applications, in a way that is simple and convenient. In 2023, we've implemented a number of digital solutions to improve access to and management of care for our patients. Key highlights include: Patient Texting Appointment Reminders --8.6M outbound appointment reminder text messages sent, leading to a 71% confirmation rate --If patients responded they needed to cancel the appointment, they were immediately texted by agents in the Patient Access Center to reschedule at a time convenient for them Care Gap Closure --From May to September 2023, more than 45,700 text messages sent to patients due for a mammogram, with 6,343 screenings scheduled --12% of patients had a positive result requiring further testing Online Appointment Scheduling --In addition to primary care and specialty services, we expanded online appointment scheduling to screening mammograms and lab services --15,800+ appointments were scheduled online, a 33% increase year over year Patient Access Center (PAC) Our PAC continues to grow exponentially, with a 41% increase in volume in 2023. The PAC started scheduling for 35 new physician practices, as well as many hospital outpatient services, totaling 1.5 million contacts throughout the year. --With growth, PAC continues to exceed industry standards in responsiveness - answering calls within 30 seconds --Call abandonment rate also exceeds industry standards,remaining belowing 5% Hackensack Meridian Neuroscience Institute Officially Launches Hackensack Meridian Health's three nationally recognized neuroscience institutes at Hackensack University Medical Center, JFK University Medical Center and Jersey Shore University Medical Center united to form the Hackensack Meridian Neuroscience Institute - the largest, most comprehensive Neuroscience Institute in New Jersey. By coming together as one institute with a shared vision and mission, the three locations have strengthened their ability to provide integrated access to care and research for patients throughout New Jersey. Under the Hackensack Meridian Neuroscience Institute umbrella, neurology and neurosurgery team members can now leverage the network resources to provide their patients with enhanced access to evidence-based care protocols, clinical trials, technology, and subspecialty expertise - closer to home, and without the need to refer patients outside Hackensack Meridian Health. Newly Unveiled Neuroscience Treatment Center In January 2023, Jersey Shore University Medical Center celebrated the opening of the Harris Neuroscience Treatment Center. The expansive, nearly 10,000 sq. foot, combined physician office and treatment center is home to experts in several neurological diseases and conditions and is part of Hackensack Meridian Neuroscience Institute. Patients can visit their physicians and other providers at the center to receive advanced diagnostic testing and treatments in a range of conditions, including; ALS (amyotrophic lateral sclerosis) and other neuromuscular disorders; Parkinson's disease, essential tremor, dystonia and other movement disorders; neuro-oncology including brain and spine tumor treatments; epilepsy and seizure disorders; headaches and migraines and stroke prevention. Hospital From Home The Hospital From Home program - which piloted at Jersey Shore University Medical Center and JFK University Medical Center in 2022 - expanded to Hackensack University Medical Center in June 2023. The program leverages at-home visits, telehealth and other technologies to provide hospital-level care to eligible patients in their homes. Patients who are otherwise healthy can comfortably connect with their care team through daily in-home nursing visits and physician check-ins via telehealth. Services provided to patients in their homes include but are not limited to: --Medications (including IV and infusion therapy) --Laboratory --Meals and nutrition --Rehabilitation services (including physical, occupational and speech therapy) --Durable medical equipment and oxygen --Diagnostic imaging (x-ray and other mobile scans) --Remote patient monitoring Surveys consistently show that people prefer to be cared for in their homes. As a result, Hospital From Home patients report higher satisfaction with their physician, comfort, convenience of care, admission process and overall care experience. At our Hospital From Home sites, patients expressed high satisfaction with the program and the convenience of receiving hospital-level care and monitoring in their homes. |
| Form 990, Part III, Line 3 STMT OF PROGRAM SERVICES ACCOMPLISHMENTS (CONTINUED) | Academics ========== Our goal is to be an international leader in physician education and research. The Hackensack Meridian School of Medicine and academic programs throughout our network define academic excellence. Continued Growth in 2023 - Totals 1,600+ faculty members - More than 90% are Hackensack Meridian Health physicians - 6,000+ applications for the 2023 cohort (up 186% since the school opened in 2018) - 167 students in the 2023 cohort (an increase from 60 students in the 2018 cohort) Commencement 2023: A Celebration In June 2023, 85 students graduated from the Hackensack Meridian School of Medicine, beginning their careers as doctors. The graduating class included students from the 2019 medical school cohort (56 students) who graduated after four years; and the 2020 cohort (29 students), who completed their education in three years. New Jersey Governor Phil Murphy delivered the commencement keynote and commended the school for its continuing commitment to medical education in the state. More than half of our graduates will continue on to serve as residents at our own Hackensack Meridian Health hospitals, while others will serve in residency programs throughout the country. Other exciting 2023 School of Medicine highlights include: - The inaugural Medical Education Week, which featured workshops, presentations, journal clubs, discussions, and awards that highlighted the work of faculty, staff, students, and residents across the Hackensack Meridian Health network. - The school's second annual Medical Student Research Day, which featured more than 80 research posters by students, two featured student presenters, and a keynote speech from Rachel Rosenstein, M.D., Ph.D., an assistant professor of internal medicine and an assistant member of the Hackensack Meridian Center for Discovery and Innovation. - The fourth annual Medical Internship Navigating Diversity and Science (M.I.N.D.S) program, which once again offered lessons in phlebotomy for high school students who are planning careers in medicine. Achieving Full Accreditation The Hackensack Meridian School of Medicine was granted full accreditation in February 2023 by the Liaison Committee on Medical Education (LCME), a major milestone capping a robust seven-year review process that affirms the highest standards in the training of future physicians. This significant milestone follows the November 2022 announcement that the school was granted full accreditation by the Middle States Commission on Higher Education (MSCHE), an affirmation that extended the School's privilege to grant M.D. degrees and allows the School to state confidently that "Our students are well-served; society is well-served." Residency and Fellowship Programs Hackensack Meridian Health has several, robust educational programs to support the advancement of our future clinicians. - 66 Residency and fellowship programs - 811 Residents and fellows enrolled Research We are dedicated to building an internationally recognized research enterprise that leads the frontier of medicine through a frictionless system of translational science and innovation. Expanding Access to Phase I Clinical Trials Phase I clinical trials provide new, first-in-human cancer treatment options through novel targeted therapies, immunotherapies, cell therapies and combination therapies. Experts from Hackensack University Medical Center's John Theurer Cancer Center extended the center's Phase I clinical trial program to Jersey Shore University Medical Center - providing close-to-home access and new hope for patients in southern New Jersey. Phase I trials are typically reserved for patients with advanced cancers who have not succeeded with therapies known for their clinical effectiveness and are interested in trying another option. John Theurer Cancer Center first expanded to Jersey Shore University Medical Center's HOPE Tower in the spring of 2022. It is part of the Georgetown Lombardi Comprehensive Cancer Center and is best known for having a nationally recognized blood cancers program and one of the largest nationwide Bone Marrow Transplant programs. These services are now also available at Jersey Shore University Medical Center. Center for Discovery and Innovation Expands Exponentially ======= In under four years of existence, the Hackensack Meridian Center for Discovery and Innovation (CDI) has experienced tremendous growth. With a mission to develop and translate innovations in biomedical sciences to improve clinical outcomes for cancer patients and others with life threatening, disabling and chronic diseases, see where we are today: - 180+ Scientists and support personnel working at the foremost of biomedical discovery and innovation. - $175 Million in research commitments over the next 5 years through government, pharmaceuticals, biotech, and foundation sectors, as well as private philanthropy. - 2,500+ Peer-reviewed Papers by faculty in leading journals. - 128,000 Net Square Feet of newly renovated research space including 38,000-foot vivarium; and another 60,000 feet of expansion space. NEW Institute for Immunologic Intervention (3i) The CDI has formed a new institute aimed at fighting infections, cancer and inflammatory diseases by finding a better way to restore and bolster the human immune system in its response to disease. The Institute for Immunologic Intervention (or "3i") led by director, Binfeng Lu, Ph.D., is searching for ways to unleash new advances in immunology to beat disease and save lives. Through a strong collaboration between CDI, John Theurer Cancer Center and its consortium partner Georgetown University's Lombardi Comprehensive Cancer Center, and others, 3i strives to apply clinical knowledge and innovative strategies to enhance the effectiveness of cancer immunotherapy, interventions for autoimmune and alloimmune conditions, and the prevention of infections. Philanthropy ============ The power of philanthropy is essential to the work that we do, as it allows us to address complex health challenges, implement community health initiatives and create a lasting impact for our patients and team members. We thank our donors and corporate partners from the bottom of our hearts for your support. 2023 Philanthropic Outcomes at a Glance - $161,517,961 Raised - 13,467 Total Donors - 50,482 Gifts The following we share a few of the many philanthropic highlights from the past year. It is with extreme gratitude that we thank our donors. Shining Bright: The Generous Giving Continues In 2023, a generous donor continued their incredibly generous support of Hackensack Meridian Health with a transformational gift to Jersey Shore University Medical Center to improve patient care. Funds contributed supported the High Intensity Focused Ultrasound (HIFU) program, technology that treats hand tremors and other involuntary, rhythmic shaking associated with Parkinson's Disease and other neurological conditions. The HIFU procedure is noninvasive, requires no incisions, and is performed while the patient is awake. Additionally, these generous donation supported the construction of an 8-bed Epilepsy Monitoring Unit (EMU) which will be equipped with computer-based monitoring equipment expressly designed for the evaluation of epilepsy and other seizure disorders. The EMU will bring together specially trained experts in technology and patient care specific to patients with epilepsy. Furthermore, this wonderful gift supported a new Computed Tomography (CT) Scanner which will be used to detect blood clots (stroke), brain tumors and cysts, brain damage from traumatic head injury, hydrocephalus, brain damage causing epilepsy, encephalitis and multiple sclerosis, among other disorders. We are filled with gratitude for our generous donors continued and steadfast partnership. Their historical giving, which includes the extremely generous purchase of the ZAP-X Gyroscopic Radiosurgery with Synaptive brain only silent MRI for the treatment of brain tumors and other conditions - the only combination of this technology in the world, as well as these most recent and significant contributions, are transforming care for the community. In Jersey Shore's first eight weeks utilizing ZAP-X, radiosurgery was delivered to 30 new patients with 87 total treatments administered. This represents the most radiosurgery done to date by any ZAP-X program in their first two months of operation. We are so grateful for our generous donors incredible support! |
| Form 990, Part III, Line 3 STMT OF PROGRAM SERVICES ACCOMPLISHMENTS (CONTINUED) | Partnerships ======== Having strong partners ensures diverse expertise, resources, and collaboration to foster innovation, improve patient care, enhance operational efficiency, expand access, and drive health care transformation for the benefit of all. Expanding World-Class Cancer Care with St. Joseph's Health Our clinical affiliation with St. Joseph's Health expanded with a new cancer center in Totowa in June 2023. The Infusion Center at St. Joseph's Health Wayne Medical Center campus was the first step in the oncology partnership - which provides better access to clinical trials and highly subspecialized expertise for patients across the St. Joseph's market. The new cancer center, spanning 70,000 square feet in Totowa, is the marquee facility of the partnering organizations' three enhanced cancer centers - a combined effort to bring comprehensive cancer care throughout the region. Cancer patients are treated at the new outpatient facility by the very best multi-disciplinary, disease-specific teams of specialists, experts, and medical practitioners to support them through every aspect of their cancer journey, from screening and diagnosis to treatment and survivorship. The community now has expanded access to care delivered by our world-renowned John Theurer Cancer Center experts. Expanding Access to Primary Care Hackensack Meridian Health and One Medical, a leading national virtual and in-office primary care organization, announced a new partnership to deliver a new human-centered and technology-powered primary care option in New Jersey. The collaboration will provide more primary care providers in New Jersey and will ensure that residents and employers have seamless coordinated care through One Medical's innovative care model and Hackensack Meridian Health's integrated network. The partnership will benefit individuals through One Medical's membership model, while employers can sponsor memberships on behalf of their employees and dependents. So far, more than 8,500 employers have participated in One Medical's services throughout the U.S. Braven Health Now Offered Statewide In 2023, Braven Healthsm - New Jersey's first and only Medicare company jointly owned by a health insurer and health systems, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and RWJBarnabas Health - expanded beyond its original 8-county service area, offering Medicare Advantage Plans statewide. With nearly 44,000 enrolled as of 2023, Braven Health is expected to show continued growth with unique coverage plans available across the state. Making Strides in Improving Maternal and Behavioral Health To support continued population health improvement across New Jersey, the Department of Health developed and implemented a hospital performance initiative called the Quality Improvement Program - New Jersey (QIP-NJ). The initiative was officially launched on July 1, 2021, after approval from the Centers for Medicare and Medicaid Services. Hackensack Meridian Health is participating in the QIP-NJ program with outstanding results - and making a positive impact in the lives of patients across our network. At Hackensack Meridian Health, the QIP-NJ team cares for the whole patient by focusing on five social determinants of health: 1. Food Insecurity 2. Housing Instability 3. Transportation 4. Social Support 5. Domestic Violence We also have many community partnerships in place that support patients, their families and team members. In November 2023, five of our QIP-NJ team members traveled to Atlanta to present program results at the American Public Health Association Conference, serving as an inspiration to colleagues across the nation. 2023 QIP-NJ Results - 7,053 Patients Enrolled - 8,664 Appointments Made - 9,331 Resources Provided (including free medications, transportation, blood pressure machines, supplies for babies and more) - 72% Reduced Odds of Being Readmitted Within 30-Days Community It is our responsibility to safeguard the earth, and help our people and communities thrive. We are deeply committed to improving quality of life and creating innovative ways to bridge health equity gaps to ensure that all patients achieve their best health. Increasing Access to Care There are a number of programs to help uninsured, or underinsured patients get access to the care they need. Our team was proud to deliver the following free, or low cost services in 2023: - 158,996 prescription medications (30-day supply) provided to patients at bedside, prior to discharge through the Meds to Bed and Dispensary of Hope programs. 54,632 patient visits to our Family Health Centers - 38,790 transported patients to necessary appointments - 7,654 at our dental clinics - 3,027 received HIV testing and education through the HIV & AIDS Ambulatory Care Clinic at Jersey Shore University Medical Center Energy Efficient Facilities Hackensack Meridian Health signed a 30 Megawatt on-site renewable energy deal which will put solar and battery storage at 12 of our hospital campuses, making us one of the health systems with the largest amount of on-site renewable energy in the country. This will reduce our emissions by over 11,307 metric tons of CO2 and save us $7.3 million a year. With continued partnerships with utility companies, we have over $64 million in active energy efficiency projects. One of the major projects underway is at Jersey Shore University Medical Center with an investment of $18.7 million which will save 5,713,316 kwh of electricity, 1,279,902 therms and10,872 metric tons of CO2. Network-Wide "Green OR" Efforts In 2023, we continued efforts to reduce energy, supply costs and waste in operating rooms across the network, utilizing Greening the OR resources from Practice Greenhealth. As a result, we saved $1,711,289 by reprocessing medical devices, diverted 40,088 pounds from landfill and saved $235,300 by lessening unnecessary supplies in operating room kits. In addition, Ocean University Medical Center, Jersey Shore University Medical Center, Hackensack University Medical Center and Southern Ocean Medical Center received the Greening the OR Recognition Award. - Electronics -100% of the electronics we purchased in 2023 were EPEAT certified, including $2,861,882 worth of laptops, monitors, mobile phones and imaging equipment. - Food -We continued to focus on increasing the amount of plant- forward dishes offered in our retail dining and patient menus and making sustainable purchases - 53.39% of the meat we purchased was antibiotic-free, and enhanced our partnership with local suppliers such as the Common Market. Overall, we invested nearly $2 million in sourcing food from local farmers. - Furnishings -We purchased over $4.6 million worth of furnishings,100% of which were free of polyvinyl chloride, formaldehyde, flame retardants, antimicrobials and perfluorinated compounds. - Green Cleaning -97% of our cleaning products were third-party eco-logo certified (green) - Summer Green Team Program: -We continued our partnership with the PSEG Institute for Sustainability Studies at Montclair State University. In the summer of 2023 we hosted a team of students that helped us develop a plan to reduce the footprint of our vehicle fleet. Diversity Equity and Inclusion: Ranked #1 in the U.S. ============================================ Our DEI Business Case Pillars PATIENT CARE & OUTCOMES - Enhancing patient care and outcomes to create more equitable health care COMMUNITY - Supporting and strengthening partnerships with the diverse communities we serve WORKFORCE - Attracting, retaining, developing and promoting the advancement of diverse talent to drive innovation and growth SUPPLIER DIVERSITY - Engaging and supporting local and diverse businesses with a focus on historically underrepresented business owners |
| Form 990, Part III, Line 3 STMT OF PROGRAM SERVICES ACCOMPLISHMENTS | Spotlight on DEI Initiatives Our Antiracism Statement At Hackensack Meridian Health, we stand against racism of all forms. We acknowledge that systemic, structural racism is the root cause of many social determinants of health and that it has a detrimental impact on our patients, staff and the communities we serve. We are intentional in our efforts to address systemic structures that perpetuate racism and contribute to health care disparities. Leadership starts at the top and our comprehensive diversity equity and inclusion governance structure ensures leadership accountability that is inclusive of team member engagement at all levels. Additionally, our blueprint for antiracism provides a roadmap for action as we work to address challenges, disparities in health care, inclusion and equity for all. As we continue on this journey, our commitment is to Keep Getting Better. In 2023, we launched Antiracism, Upstander and Allyship training courses to further support these efforts. Annual Days of Understanding and Listening To Understand: With the country's ongoing and ever evolving social and cultural landscape, we continued two key programs in 2023 - our Annual Days of Understanding and our monthly Listening to Understand discussion groups. These programs encourage our 37,000 team members to participate in difficult conversations about race, social justice, socio-economic and even global events in a safe, nonjudgmental environment. Supplier Diversity Throughout 2023, we continued our efforts to support a more diverse supply chain. One highlight included the first Virtual Supplier Diversity Showcase, held in partnership with the African American Chamber of Commerce NJ. At that time, there was a critical shortage of a specific cancer treatment drug. Broughton Pharmaceuticals, one of the Showcase presenters, was able to provide the drug immediately. Through this successful collaboration with a diverse vendor, our patients were able to access a critical drug needed for cancer therapy. Our Supplier Diversity Mentorship program continued in 2023. The mentoring/protege program focuses on enhancing the specialized capabilities of disadvantaged small businesses in their efforts to secure large private and public agency construction projects. Unconscious Bias Training Our entire workforce was trained on unconscious bias in 2023, with a 100% completion rate. This customized training introduced team members and leaders to the concept of unconscious bias while allowing them to explore the impact of such biases on our work and patient care environment. Addressing unconscious bias is a critical component of our overall Diversity Equity & Inclusion strategy to enforce health equity for our patients and create a more inclusive workplace for all. Team Member Resource Groups We are proud to offer voluntary groups organized around particular shared interests or dimensions of diversity. These groups provide open forums to do the following: share innovative ideas; foster cultural awareness and culturally competent care; enhance engagement; create a sense of belonging and well-being; help accomplish business goals; build professional development and networking opportunities; identify high-potential and diverse talent; and strengthen the connections within communities while addressing health equity. In September 2023, we held the third annual Team Member Resource Group Town Hall with the CEO, Robert C. Garrett. In addition, we established and implemented the Inaugural Team Member Resource Group Impact Award for Health Equity. Team Member Resource Groups are as follows: -Abilities -Asian (Launched April 2023) -Aspiring Women Leaders -Black -Interfaith (Launched in December 2023) -Latinx/Hispanic (Launched December 2022) -Multicultural -Pride and Allies -Veterans -Women in Leadership -Young Professionals National Recognition All 13 Hackensack Meridian Health's hospitals have been recognized as a "Leader "Top Performer" by the Human Rights Campaign (HRC) Foundation's Healthcare Equality Index (HEI) for their commitment to equitable and inclusive care of lesbian, gay, bisexual, transgender and queer (LGBTQ) patients, their families and team members. This national benchmarking tool evaluates health care facilities' LGBTQ-inclusive policies and best practices to provide culturally competent health care of the highest quality. Eleven hospitals earned "LGBTQ+ Healthcare Equality Leader" designation - with a perfect score of 100: Bayshore Medical Center,Holmdel Hackensack University Medical Center, Hackensack Jersey Shore University Medical Center,Neptune City JFK University Medical Center, Edison Mountainside Medical Center, Montclair Ocean University Medical Center, Brick Old Bridge Medical Center, Old Bridge Pascack Valley Medical Center, Westwood Raritan Bay Medical Center, Perth Amboy Riverview Medical Center, Red Bank Southern Ocean Medical Center, Manahawkin Two hospitals earned the HEI "Top Performer" - scoring from 80 to 95 points. Each hospital below received a score of 95: Carrier Clinic, Belle Mead Palisades Medical Center, North Bergen First to Receive Health Equity Certification Hackensack University Medical Center was the first hospital in the nation to receive the Health Care Equity Certification from The Joint Commission, which was announced in July 2023, with three additional hospitals within the network following with this prestigious recognition, including Jersey Shore University Medical Center, Ocean University Medical Center and Palisades Medical Center. The certification indicates Hackensack Meridian Health's extensive efforts to address and improve health care equity across its network. Awards and Recognition ==================== Magnet 2023 HMH hospitals have been Magnet-designated for nearly 30 years. In 2023, four hospitals applied for this prestigious designation from the American Nurses Credentialing Center. Raritan Bay Medical Center and Old Bridge Medical Center secured its 5th designation, JFK University Medical Center successfully achieved its first designation, and Hackensack University Medical Center earned its 7th designation. Hackensack was the first hospital in New Jersey to earn this designation seven times and is one of only three hospitals in the country to achieve this distinction. 2023 built on the success of 2022, where five hospitals attained Magnet re-designation. This includes Bayshore Medical Center - 2nd designation; Jersey Shore University Medical Center - 6th designation; Ocean University Medical Center - 6th designation; Riverview Medical Center - 6th designation; and, Southern Ocean Medical Center - 2nd designation. The distinguished Magnet Recognition Program is recognized as the gold standard of nursing excellence, with just 9.4 percent of hospitals in the United States receiving this designation. |
| Form 990, Part III, Line 4d Description of other program services | (Expenses $ 3,944,500,744 including grants of $ 250,270,543)(Revenue $ 4,149,457,713) PROVIDING VARIOUS OTHER MEDICALLY NECESSARY HEALTHCARE SERVICES, SUCH AS EMERGENCY DEPARTMENT, OBSTETRICS & NEWBORNS, CHEMOTHERAPY, ONCOLOGY, BEHAVIORAL HEALTH, ETC., TO ALL INDIVIDUALS IN A NON-DISCRIMINATORY MANNER REGARDLESS OF RACE, COLOR, CREED, SEX, NATIONAL ORIGIN OR ABILITY TO PAY. |
| Form 990, Part VI, Line 1a Material differences in voting rights | The Executive Committee shall have the delegated authority to transact the regular business of the Corporation and to implement the policy decisions of the Board during the interim between the meetings of the Board; provided, however, that such delegation of authority conforms with the subsequent approval requirements noted in the bylaws and that no act taken by the Executive Committee shall conflict with the acts of the Board, the limitations imposed by the Board in these Bylaws or the Member Reserved Powers. The Executive Committee shall consist of the Officers of the Corporation, the Chairperson of the HMH Board, the CEO of the Member, for a total of eight (8) voting members. |
| Form 990, Part VI, Line 2 Family/business relationships amongst interested persons | CHARLES V. SCHAEFER , III AND CAROL D. SCHAEFER - Family relationship, MARIO MARGHELLA AND SHANE SULLIVAN - Family relationship |
| Form 990, Part VI, Line 4 Significant changes to organizational documents | UNDER THE AUTHORITY OF THE BOARD OF TRUSTEES, DUE TO CHANGE OF ACCOUNTING PERIOD ACTIVITY, THE FOLLOWING ORGANIZATION WAS ADDED AS A SUPPORTED ORGANIZATION IN 2023: HACKENSACK MERIDIAN SCHOOL OF MEDICINE (EIN: 81-3872529). |
| Form 990, Part VI, Line 6 Classes of members or stockholders | HACKENSACK MERIDIAN HEALTH, INc. ("HMH") IS THE SOLE MEMBER OF ALL SUBORDINATE ORGANIZATIONS INCLUDED IN THE HACKENSACK MERIDIAN HEALTH, INC. GROUP EXEMPTION RULING AND THIS CONSOLIDATED GROUP FORM 990 OTHER THAN HEALTH INNOVATIONS UNLIMITED, INC. ("HIU"). HMH HAS THE RIGHT TO ELECT THE MEMBERS OF EACH SUBORDINATE ORGANIZATION'S BOARD OF TRUSTEES AND HAS CERTAIN RESERVED POWERS AS DEFINED IN EACH SUBORDINATE ORGANIZATION'S BYLAWS. HACKENSACK MERIDIAN AMBULATORY CARE, INC., A SUBORDINATE INCLUDED IN THE HACKENSACK MERIDIAN HEALTH, INC. GROUP EXEMPTION RULING AND THIS CONSOLIDATED GROUP FORM 990, HAS THE RIGHT TO ELECT THE MEMBERS OF HIU'S BOARD OF TRUSTEES AND HAS CERTAIN RESERVED POWERS AS DEFINED IN HIU'S BYLAWS. |
| Form 990, Part VI, Line 7a Members or stockholders electing members of governing body | REFER TO THE ABOVE NARRATIVE ON PART VI, LINE 6. |
| Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders | REFER TO THE ABOVE NARRATIVE ON PART VI, LINE 6. |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | THE SUBORDINATE ORGANIZATIONS ARE SUBSIDIARIES OF HACKENSACK MERIDIAN HEALTH, INC. ("HMH"); A TAX-EXEMPT INTEGRATED HEALTHCARE DELIVERY NETWORK. HMH'S FINANCE PERSONNEL PREPARED THE FEDERAL FORM 990, WHICH WAS THEN REVIEWED BY OTHER APPROPRIATE INTERNAL STAFF FOR ACCURACY. HMH RETAINED A FIRM OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS WITH EXPERIENCE AND EXPERTISE IN HEALTH CARE AND NOT-FOR-PROFIT TAX RETURN PREPARATION TO REVIEW AND FILE THE FORM 990. HMH'S BOARD OF TRUSTEES DESIGNATED THE AUDIT AND COMPLIANCE COMMITTEE ("ACC") TO REVIEW THE FORM 990 OF HMH'S SUBSIDIARIES. THE FORM 990 WAS PROVIDED TO THE MEMBERS OF THE ACC FOR REVIEW. THE PORTIONS OF THE FORM 990 PROVIDING COMPENSATION DISCLOSURES WERE ALSO PROVIDED TO THE BOARD'S EXECUTIVE AND PHYSICIAN COMPENSATION COMMITTEE FOR REVIEW. THE FORM 990, EXCLUDING SCHEDULE B, TO HONOR THE REQUEST FOR CONFIDENTIALITY OF A DONOR, WAS THEN PROVIDED TO EACH VOTING MEMBER OF HMH'S GOVERNING BODY, ITS BOARD OF TRUSTEES, PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. IN ACCORDANCE WITH CODE SECTION 6033, DONOR INFORMATION ON SCHEDULE B IS INCLUDED ON THE FORM 990 TO BE FILED WITH THE INTERNAL REVENUE SERVICE. THE HMH BOARD OF TRUSTEES HAS THE FINAL GOVERNING AUTHORITY OVER THE SUBSIDIARIES OF HMH. |
| Form 990, Part VI, Line 12c Conflict of interest policy | HACKENSACK MERIDIAN HEALTH, INC., THE TAX-EXEMPT PARENT ORGANIZATION OF HACKENSACK MERIDIAN HEALTH, A TAX-EXEMPT INTEGRATED HEALTHCARE DELIVERY NETWORK, HAS ADOPTED A NETWORK-WIDE CONFLICT OF INTEREST POLICY WHICH IS APPLICABLE TO ALL OF ITS SUBSIDIARY ORGANIZATIONS. THE ORGANIZATIONS REGULARLY MONITOR AND ENFORCE COMPLIANCE WITH THE NETWORK'S CONFLICT OF INTEREST POLICY. ANNUALLY, ALL MEMBERS OF THE BOARD OF TRUSTEES, OFFICERS AND KEY EMPLOYEES OF EACH ORGANIZATION ARE REQUIRED TO REVIEW THE EXISTING CONFLICT OF INTEREST POLICY AND COMPLETE A QUESTIONNAIRE WITH RESPECT TO ANY APPLICABLE TRANSACTIONS AND RELATIONSHIPS. THE COMPLETED QUESTIONNAIRES ARE RETURNED TO THE NETWORK'S CHIEF COMPLIANCE OFFICER FOR REVIEW. THE CHIEF COMPLIANCE OFFICER THEN PREPARES A SUMMARY OF THE COMPLETED QUESTIONNAIRES, AND PRESENTS THE SUMMARY TO THE NETWORK'S GOVERNANCE AND BOARD DEVELOPMENT COMMITTEE FOR ITS REVIEW, DISCUSSION AND ACTION (IF NEEDED). ANY TRUSTEE, OFFICER OR KEY EMPLOYEE WITH A DISCLOSED CONFLICT WOULD RECUSE THEMSELVES FROM PARTICIPATING IN THE GOVERNING BODY'S DELIBERATIONS AND DECISIONS OF A TRANSACTION IN QUESTION. DURING THE YEAR, THE CHIEF COMPLIANCE OFFICER IN CONJUNCTION WITH THE CHIEF LEGAL OFFICERS ALSO MONITORS ON-GOING TRANSACTIONS IN LIGHT OF THE SUMMARY TO ENSURE THAT ANY POTENTIAL CONFLICTS OF INTEREST ARE APPROPRIATELY HANDLED IN COMPLIANCE WITH THE POLICY. |
| Form 990, Part VI, Line 15a Process to establish compensation of top management official | THE ORGANIZATIONS ARE AFFILIATES WITHIN A TAX-EXEMPT INTEGRATED HEALTHCARE DELIVERY NETWORK IN WHICH HACKENSACK MERIDIAN HEALTH, INC. IS THE TAX-EXEMPT PARENT ORGANIZATION. THE EXECUTIVE AND PHYSICIAN COMPENSATION COMMITTEE ("COMMITTEE") OF HACKENSACK MERIDIAN HEALTH, INC. IS RESPONSIBLE FOR REVIEWING THE EXECUTIVE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER AND SPECIFIED KEY EMPLOYEES (SENIOR MANAGEMENT) OF THE PARENT AND ALL OF THE SUBSIDIARY ORGANIZATIONS. THE COMMITTEE HAS ADOPTED A WRITTEN EXECUTIVE COMPENSATION PHILOSOPHY, WHICH IT FOLLOWS WHEN IT REVIEWS AND APPROVES COMPENSATION AND BENEFITS. THE EXECUTIVE COMPENSATION PHILOSOPHY RECOGNIZES THE SIZE AND COMPLEXITY OF THE HEALTH CARE NETWORK AND THE CRITICAL NEED TO HAVE AND RETAIN EXECUTIVES THAT CONSISTENTLY DEMONSTRATE SUPERIOR LEVELS OF PERFORMANCE SO THAT THE HEALTH NETWORK CAN FULFILL ITS CHARITABLE MISSION AND STRATEGIC OBJECTIVES. THE COMMITTEE REVIEWS THE "TOTAL COMPENSATION", INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION AND ALL EMPLOYEE BENEFITS, BOTH QUALIFIED AND NON-QUALIFIED, ON AT LEAST AN ANNUAL BASIS TO ENSURE THAT THE "TOTAL COMPENSATION" OF THE CHIEF EXECUTIVE OFFICER, OTHER OFFICERS AND SPECIFIED MEMBERS OF SENIOR MANAGEMENT IS REASONABLE. TO ASSIST WITH THE REVIEW, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED INDEPENDENT CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTH CARE ORGANIZATIONS, AND RECEIVES NATIONAL AND REGIONAL MARKET DATA FOR COMPARABLE ORGANIZATIONS, A REPORT SUMMARIZING SUCH DATA, AND AN OPINION LETTER RELATING TO THE REASONABLENESS OF EACH REVIEWED EXECUTIVE'S TOTAL COMPENSATION AND BENEFITS. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. THE INDEPENDENT COMMITTEE UTILIZES THE OUTSIDE MARKET DATA COMPARABILITY AND, BASED UPON THE EXECUTIVE COMPENSATION PHILOSOPHY, THE ORGANIZATION'S PERFORMANCE, BUSINESS JUDGMENT CONSIDERATIONS, AND THE INDIVIDUAL'S PERFORMANCE, REVIEWS AND APPROVES COMPENSATION FOR THE REVIEWED MEMBERS OF SENIOR MANAGEMENT. GUIDED AT EACH MEETING BY OUTSIDE COUNSEL TO THE COMMITTEE, THE COMPREHENSIVE REVIEW PROCESS UTILIZED BY THE COMMITTEE IS INTENTIONALLY STRUCTURED TO QUALIFY FOR THE REBUTTAL PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: 1. THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY THE COMMITTEE, WHICH IS AN "AUTHORIZED BODY" OF THE ORGANIZATION COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE IRS REGULATIONS UNDER SECTION 4958; 2. THE COMMITTEE OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY (FOR COMPARABLE POSITIONS AT SIMILAR HEALTHCARE ORGANIZATIONS) PRIOR TO MAKING ITS DETERMINATION, WHICH COMPARABILITY DATA IS PROVIDED AND ANALYZED BY THE COMMITTEE'S INDEPENDENT CONSULTING FIRM WITH EXPERTISE IN THE AREA OF NOT-FOR-PROFIT HEALTH CARE EXECUTIVE COMPENSATION; AND 3. THE COMMITTEE THOROUGHLY DOCUMENTS ITS REVIEW AND APPROVAL PROCESS, AS WELL AS THE BASIS FOR ITS APPROVALS, CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS DESCRIBED IN THE IRS REGULATIONS. AS APPROPRIATE, THE COMMITTEE SUPPLEMENTS THE COMPARABILITY DATA WITH OTHER OBJECTIVE FACTORS DESIGNED TO ENSURE THE REASONABLENESS OF THE COMPENSATION PAID, INCLUDING AN ANALYSIS OF INDIVIDUAL GOALS AND OBJECTIVES, ORGANIZATIONAL PERFORMANCE, PERSONNEL REVIEWS, EVALUATIONS, SELF-EVALUATIONS, AND ANY WRITTEN OFFERS FROM COMPETING ORGANIZATIONS. THE COMPENSATION ARRANGEMENTS APPROVED BY THE COMMITTEE ARE REPORTED IN EXECUTIVE SESSION TO THE FULL BOARD BY THE CHAIR AND VICE CHAIR OF THE COMMITTEE. |
| Form 990, Part VI, Line 15b Process to establish compensation of other employees | REFER TO THE ABOVE NARRATIVE ON PART VI, LINE 15A. |
| Form 990, Part VI, Line 19 Required documents available to the public | THE SUBORDINATE ORGANIZATIONS INCLUDED IN THE HACKENSACK MERIDIAN HEALTH, INC. GROUP EXEMPTION RULING AND THIS CONSOLIDATED GROUP FORM 990 ARE AFFILIATES WITHIN HACKENSACK MERIDIAN HEALTH; A TAX-EXEMPT INTEGRATED HEALTH CARE DELIVERY NETWORK ("NETWORK"). CERTAIN SUBORDINATE ORGANIZATIONS INCLUDED IN THIS CONSOLIDATED GROUP FORM 990 HAVE ISSUED TAX-EXEMPT BONDS TO FINANCE VARIOUS CAPITAL IMPROVEMENT PROJECTS, RENOVATIONS AND EQUIPMENT. ALSO, EACH SUBORDINATE ORGANIZATION'S FILED CERTIFICATE OF INCORPORATION AND ANY AMENDMENTS CAN BE OBTAINED AND REVIEWED THROUGH THE STATE OF NEW JERSEY DEPARTMENT OF THE TREASURY. THE AUDITED FINANCIAL STATEMENTS, CODE OF CONDUCT AND CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC VIA THE HACKENSACK MERIDIAN HEALTH'S WEBSITE, WWW.HACKENSACKMERIDIANHEALTH.ORG, THEIR CODE OF CONDUCT AND CONFLICT OF INTEREST POLICY. |
| Form 990, Part VII, Section A Members Serve On More Than One Board | PART VII AND SCHEDULE J REFLECT CERTAIN INDIVIDUALS WHO WORKED FULL-TIME FOR HACKENSACK MERIDIAN HEALTH AND RECEIVED COMPENSATION AND BENEFITS FOR SERVICES RENDERED TO SUBORDINATES OF HACKENSACK MERIDIAN HEALTH. PLEASE NOTE THIS REMUNERATION WAS FOR SERVICES RENDERED TO A RELATED ORGANIZATION AND NOT FOR SERVICES RENDERED AS A VOTING MEMBER OR OFFICER OF THIS ORGANIZATION'S BOARD OF TRUSTEES. PLEASE NOTE THAT THIS FORM 990 REFLECTS THE FINANCIAL ACTIVITY AND OTHER INFORMATION OF THE SUBORDINATE ORGANIZATIONS INCLUDED IN THE HACKENSACK MERIDIAN HEALTH,INC. GROUP EXEMPTION RULING BUT DOES NOT INCLUDE ALL RELATED ORGANIZATIONS. PART VII INCLUDES, AS OF DECEMBER 31, 2023, THE MEMBERS OF THE BOARD OF TRUSTEES, OFFICERS, AND KEY EMPLOYEES OF EACH OF THE ORGANIZATIONS INCLUDED IN THIS CONSOLIDATED GROUP FORM 990. IN ADDITION, PART VII INCLUDES THE REMAINING TOP FIVE HIGHEST PAID EMPLOYEES AMONGST ALL ENTITIES COMBINED AFTER OFFICERS AND KEY EMPLOYEES OF ALL ORGANIZATIONS INCLUDED IN THE HACKENSACK MERIDIAN HEALTH, INC. GROUP EXEMPTION RULING AND THIS CONSOLIDATED GROUP FORM 990. THESE TRUSTEES, OFFICERS, KEY EMPLOYEES AND HIGHEST PAID EMPLOYEES ARE LISTED IN ORDER FROM HIGHEST TO LOWEST COMPENSATION. OUTLINED BELOW IS A SUMMARY OF THE BOARD OF TRUSTEES BY ORGANIZATION. [* INDICATES THE MEMBER SERVES ON MORE THAN ONE BOARD REPORTED ON THIS GROUP RETURN]: HMH HOSPITALS CORPORATION =========================== Richard Henning Marvin Goldstein, Esq. Rosemarie J. Sorce* Robert C. Garrett, FACHE* William Lawless, Ph.D. Gloria Martini* Aida Capo, M.D. Gregorio Guillen, M.D. Luke Kealy, Esq. Thomas Lake, M.D. Steven Lisser, M.D. William J. Murray* Edward Piccinich Shawn Reynolds* Andria Schneiderman Pranaychandra Vaidya, M.D. Frank J. Vuono* John Wilcha* Walter Wynkoop, M.D. Frank L. Fekete, CPA* Mark Stauder* Christopher A. Rotio* Praful Raja* Edward Russo (Termed 7/19/2023) HACKENSACK MERIDIAN AMBULATORY CARE, INC. ========================================= Ulises E. Diaz* Gloria Martini* Maris Lown* Christopher Maher* Katherine York* Robert C. Garrett, FACHE* Frank L. Fekete, CPA* Mark Stauder* G. Thomas Croonquist, Jr.* James Kirkos* James M. Bollerman* James Renna* John Wilcha* Thomas J. Kononowitz* William Crane* William Hickey* William J. Murray* Alfred J. Schiavetti, Jr.* (Termed 6/28/2023) Robert O'Hara* (Termed 9/20/2023) David Epstein, Esq.* (Termed 12/31/2023) HEALTH INNOVATIONS UNLIMITED, INC. ================================= Ulises E. Diaz* Gloria Martini* Maris Lown* Christopher Maher* Katherine York* Robert C. Garrett, FACHE* Frank L. Fekete, CPA* Mark Stauder* G. Thomas Croonquist, Jr.* James Kirkos* James M. Bollerman* James Renna* John Wilcha* Thomas J. Kononowitz* William Crane* William Hickey* William J. Murray* Alfred J. Schiavetti, Jr.* (Termed 6/28/2023) Robert O'Hara* (Termed 9/20/2023) David Epstein, Esq.* (Termed 12/31/2023) HACKENSACK MERIDIAN HEALTH FOUNDATION, INC. =========================================== Robert G. Harms* Carol B. Stillwell* Heidi B. Maggs Robert C. Garrett, FACHE* Thomas J. Dolan* Walter R. Earle II* Deborah R. Mathis-Sundermann, CPA, CHBC* Evaristo F. Stanziale* Joyce Hendricks* David Sanzari* Domenic M. DiPiero, III Frank J. Vuono* Frank L. Fekete, CPA* Gail B. Gordon, Esq.* John C. Meditz* Joseph Yewaisis* Keith Banks Lawrence R. Inserra, Jr.* Mark D. Schlesinger, M.D.* Rosemarie J. Sorce* William J. Montgoris* Brian M. Nelson, Esq.* Jonathan B. Schultz* Laura Bianchini* Surender M. Grover, MD Christopher Maher* James J. Galeota* Samuel S. Raia* Alexander Duran* John Pearce Vincent J. Hager* John F. Reinhardt* Douglas Schwarz* Thomas G. Amato (Termed 2/20/2023) Skye J. Gibson (Termed 7/5/2023) John A. Giunco, Esq. (Termed 2/1/2023) Serena DiMaso, Esq. (Termed 2/1/2023) Louis J. Dughi, Esq.* (Termed 2/1/2023) HACKENSACK UNIVERSITY MEDICAL CENTER FOUNDATION, INC. ===================================================== Lawrence R. Inserra, Jr.* Robert C. Garrett, FACHE* Ulises E. Diaz* William McLaughlin Lauren Wright* James P. Andersen Nick Cangialosi Heather Won Choi G. Thomas Croonquist, Jr.* William Cunningham Michael Geary Gail B. Gordon, Esq.* William C. Hanson Richard Hubschman, Jr, Esq. Martin W. Kafafian, Esq. Sandra Keary* Sandra Kissler Patricia K. Low Michael S. McGeary Brian McLaughlin John C. Meditz* William J. Murray* Robert O'Hara, III* Samuel S. Raia* Julia Recaman Christopher A. Rotio* David Sanzari* Anthony Scardino, Jr. Carol D. Schaefer Charles V. Schaefer, III Elyssa Schecter Mark D. Schlesinger, M.D.* Charles H. Shotmeyer Rosemarie J. Sorce* Frank J. Vuono* Joyce Hendricks* Stephen Martinez Behnaz Baker Thomas Geisel Hans Schmidt, MD William Martini, Jr. Folu Okunseinde Dante A. Implicito, M.D. (Termed 2/6/23) Jerrold Langer (Termed 2/6/23) Stephen T. Boswell, PhD, PE (Termed 2/6/23) Thomas Evans (Termed 2/6/23) David T. Robertson, Esq (Termed 11/21/23) JERSEY SHORE UNIVERSITY MEDICAL CENTER FOUNDATION, INC. ====================================================== John A. Giunco, Esq. Walter R. Earle II* John F. Reinhardt* Eric M. Kirsch, CFA Philip J. Scaduto Robert C. Garrett, FACHE* Thomas B. Barham, Sr Thomas DeFelice Sandra Keary* Robert W. Mullen, Jr Kenneth D. Nahum, DO Richard M. Neibart, M.D. Philip L. Perricone Robert Smith Alexander Taylor Gary Tolchin Harpreet Pall, M.D. Richard Loshiavo Joyce Hendricks* David Kountz, MD Nicole Agnew Jamie Caulfield Isaac Massry Robert L. Sweeney, DO (Termed 5/30/23) David Epstein, Esq.* (Termed 12/31/23) RIVERVIEW MEDICAL CENTER FOUNDATION, INC. ======================================== Steven M. Scopellite Nancy B. Mulheren Peter T. Roselle Jonathan B. Schultz* Robert C. Garrett, FACHE* Negin N. Griffith, M.D. Leslie Hitchner Robert S. Morris Brian M. Nelson, Esq.* Shawn Reynolds* Margaret S. Riker Siran H. Sahakian Richard J. Saker Benedict J. Torcivia, Jr. Maria Maher Robin Klein Fred Voccola John Maggiacomo, II Joyce Hendricks* Leon F. DeJulius Thomas DeFelice, III Sarah Personette Denise Crowley DeAngelis Steven Lisser, M.D. (Termed 1/1/2023) Michael Walker (Termed 1/1/2023) OCEAN UNIVERSITY MEDICAL CENTER FOUNDATION, INC. =============================================== Robert C. Garrett, FACHE* Robert G. Harms* Gary Pieringer Louis J. Dughi, Esq.* Ali R. Moosvi, M.D. Edward J. Dimon, Esq. Frank DiTullio, III Jereme J. Kokes John V. Visceglia, Jr. Joseph S. Mignon Peter J. Mencel, M.D. Douglas Schwarz* Chuck Grinnel Helen Lucciola Joyce Hendricks* Lambros Lambrou Laura Bodman Gwen Fragomen Joseph P. Bogdan, M.D. (Termed 3/24/2023) SOUTHERN OCEAN MEDICAL CENTER FOUNDATION, INC. =============================================== Deborah R. Mathis-Sundermann, CPA, CHBC* Joan M. Hart Jeremy S. DeFilippis Joseph D. Rulli Phyllis Buttermark Robert C. Garrett, FACHE* Robert Stohrer Michael R. Aaron, DO Sean D. Kauffman Joseph P. Lattanzi, M.D. Karl W. Strom, M.D. Thomas C. Yu, M.D. Edward M. Walters, Jr. David L. Wyrsch, Jr. Christopher Fritz Judith Brophy Matthew Matey Joyce Hendricks* Thomas J. Dolan* Frances L. Signorile Ken Formica Marean Abramson Skye J. Gibson (Termed 7/5/2023) Paul K. Chung, M.D. (Termed 2/1/2023) John Imperato (Termed 10/13/2023) Angela R. Ominski (Termed 11/20/2023) BAYSHORE MEDICAL CENTER FOUNDATION, INC. ======================================== Serena DiMaso, Esq. Evaristo F. Stanziale* Carol B. Stillwell* Vincent J. Hager* Robert C. Garrett, FACHE* Gaurav Baveja Angelo DeRosa John D. DeLiso Rajiv Prasad, MD Richard Kolber Adrian M. Pristas, M.D. Asaad H. Samra, M.D. Jason Savarese Christopher M. Striano Lori Ann Davidson Courtney Fiore Joyce Hendricks* Victor Lolli RARITAN BAY HEALTHCARE FOUNDATION, INC. ====================================== Robert C. Garrett, FACHE* Surender M. Grover, M.D. Laura Bianchini* Joyce Hendricks* Adrienne Alquiros Gregorio Guillen, MD Timothy McNair Chris Sammarco Dominick A. Cama (Termed 1/1/2023) PALISADES MEDICAL CENTER FOUNDATION, INC. ======================================== John C. Meditz* Alexander Duran* Thomas Eastwick Leonard Lauricella Blanca Mankiewicz Mario Marghella Thomas Venino, Jr. Robert C. Garrett, FACHE* Shane Sullivan Joyce Hendricks* Samantha Clayton Carlos Paz Robert DiVincent (Termed 4/18/2023) |
| Form 990, Part VII, Section A Members Serve On More Than One Board (Continued) | JFK UNIVERSITY MEDICAL CENTER FOUNDATION, INC. ============================================= Joseph Yewaisis* A. Joyce Busch Steve Rothman Ankit Gupta Denise Marra Depekary, Esq. Jason Cheng John F. Kwasnik, Esq. Lorraine Mulligan Michael A. Kleiman, DMD* Peter Visceglia Praful Raja* Vincent Amabile* Katie Barnes Mary Beth Cunningham Janine Purcaro Joyce Hendricks* Robert C. Garrett, FACHE* Frank Babar John (JD) Pearce Manpreet Gill Sanket Rupareliya, MD Venk Gorty Carissa Lawson Michael Lombardi John G. McDonough, DMD (Termed 3/31/2023) MUHLENBERG FOUNDATION, INC. ============================ Robert J. Goellner O. Oliver Andersen Robert Fleschler Robert McCabe Ronald West Victor Aloyo (Termed 8/31/2023) HARTWYCK AT OAK TREE, INC. ========================= Ulises E. Diaz* Gloria Martini* Maris Lown* Christopher Maher* Katherine York* Robert C. Garrett, FACHE* Frank L. Fekete, CPA* Mark Stauder* G. Thomas Croonquist, Jr.* James Kirkos* James M. Bollerman* James Renna* John Wilcha* Thomas J. Kononowitz* William Crane* William Hickey* William J. Murray* Alfred J. Schiavetti, Jr.* (Termed 6/28/2023) Robert O'Hara* (Termed 9/20/2023) David Epstein, Esq.* (Termed 12/31/2023) HACKENSACK MERIDIAN OUTPATIENT SERVICES, INC. ============================================ Ulises E. Diaz* Gloria Martini* Maris Lown* Christopher Maher* Katherine York* Robert C. Garrett, FACHE* Frank L. Fekete, CPA* Mark Stauder* G. Thomas Croonquist, Jr.* James Kirkos* James M. Bollerman* James Renna* John Wilcha* Thomas J. Kononowitz* William Crane* William Hickey* William J. Murray* Alfred J. Schiavetti, Jr.* (Termed 6/28/2023) Robert O'Hara* (Termed 9/20/2023) David Epstein, Esq.* (Termed 12/31/2023) BERGEN HEALTH MANAGEMENT SERVICES, INC. ======================================= Mark Stauder* Robert L. Glenning Linda McHugh MUHLENBERG REGIONAL MEDICAL CENTER, INC. ======================================== Douglas A. Nordstrom Michael A. Kleiman, DMD* Amie Thornton Todd Way HMH CARRIER CLINIC, INC. =========================== Lawrence R. Inserra, Jr.* Thomas G. Amato Ann Damsgaard Caryl Kourgelis Donald J. Parker Gordon Pingicer Jaime Robertson-Lavalle Lauren Wright* Mary Pat Christie Susan B. Hassmiller, PhD, RN Robert C. Garrett, FACHE* Christian Peter CENTER FOR DISCOVERY AND INNOVATION ==================================== Andrew L. Pecora, M.D. Frank L. Fekete, CPA* Garry A. Neil, MD Harlan F. Weisman, MD James J. Galeota* Robert C. Garrett, FACHE* Roger D. Kornberg, Ph.D. Sol J. Barer, Ph.D. Thomas Polen David S. Perlin, Ph.D. Daria Hazuda Rosemary A. Crane (Termed 1/19/2023) HACKENSACK MERIDIAN SCHOOL OF MEDICINE ======================================= Robert C. Garrett, FACHE* John F. Williams, Jr., MD Mary Ann Christopher Linda Bowden Frank L. Fekete, CPA* Vincent Amabile* Amy Cradic Ulises E. Diaz* Robert S. Hekemian, Jr. Vaughn McKoy, JD William J. Montgoris* Robert O'Hara, III* Richard Park, MD Suzanne Spero Illana Raia Raymond Chambers (Termed 9/13/2023) Jennifer Velez, J.D. (Termed 11/25/2023) |
| Form 990, Part VIII, Line 2f Other Program Service Revenue | Net Rental Income (Realty & Kingsland) - Business Code 531190 - Total Revenue: 15979152, Related or Exempt Function Revenue: 15979152, Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: ; Laboratory Revenue - Business Code 621500 - Total Revenue: 26498906, Related or Exempt Function Revenue: , Unrelated Business Revenue: 26498906, Revenue Excluded from Tax Under Sections 512, 513, or 514: ; |
| Form 990, Part VIII, Line 11d Other Miscellaneous Revenue | Day Care - Total Revenue: 2411423, Related or Exempt Function Revenue: , Unrelated Business Revenue: 255491, Revenue Excluded from Tax Under Sections 512, 513, or 514: 2155932; All other revenue - Total Revenue: -26879798, Related or Exempt Function Revenue: , Unrelated Business Revenue: 4154339, Revenue Excluded from Tax Under Sections 512, 513, or 514: -31034137; |
| Form 990, Part X, Line 20 Tax-Exempt Bond Liabilities | IN ACCORDANCE WITH THE ORGANIZATION'S AUDITED FINANCIAL STATEMENTS, THE TAX-EXEMPT BOND VALUES WERE REPORTED ON THE BOOKS OF HACKENSACK MERIDIAN HEALTH, INC., THE PARENT ORGANIZATION OF THIS TAX-EXEMPT INTEGRATED HEALTHCARE DELIVERY NETWORK. AS SUCH, THE TAX-EXEMPT BONDS ARE REPORTED ON SCHEDULE K OF THE HACKENSACK MERIDIAN HEALTH, INC. FORM 990. |
| Form 990, Part XI, Line 9 Other changes in net assets or fund balances | Equity Transfer - XXX-XX-XXXX; Other Changes in Pension Related Adjustments - 96422967; Reclass SOM Investment Income from Parent to Subs 990 - -449097; NPSR Reclass from Parent to Subs - -42193088; Other Changes in Unrestricted Net Assets - 2677108; Beginning Net Assets of Entities New to the Group Exemption Ruling - 32927135; Other Changes in Temporarily Restricted Net Assets - 63514737; Other Changes in Permanently Restricted Net Assets - 7357769; Net Assets Released From Restriction for Unrestricted Use (Foundation Release) - -3529785; Mission Support Prior Period Adjustment - -2261423; |
| Form 990, Part XII, Line 2a Financial Statements | PRICEWATERHOUSE COOPERS, L.L.P. AUDITED THE CONSOLIDATED FINANCIAL STATEMENTS OF HACKENSACK MERIDIAN HEALTH, INC. FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022, INCLUDING THIS ORGANIZATION. PRICEWATERHOUSE COOPERS, L.L.P. ISSUED AN UNQUALIFIED OPINION WITH RESPECT TO THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS. THE HACKENSACK MERIDIAN HEALTH, INC. AUDIT AND COMPLIANCE COMMITTEE HAS ASSUMED RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF THE CONSOLIDATED FINANCIAL STATEMENTS, WHICH INCLUDES THE ORGANIZATIONS IN THIS CONSOLIDATED GROUP FORM 990, AND THE SELECTION OF AN INDEPENDENT AUDITOR. |
| Software ID: | 23017437 |
| Software Version: | 2023v5.1 |